Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial

被引：0
|
作者：
Chit Moy Ley
Qing Ni
Xing Liao
Huai-lin Gao
Nicola Robinson
机构：
[1] London South Bank University,School of Health and Social Care
[2] China Academy of Chinese Medical Sciences,Department of Endocrinology, Guang’anmen Hospital
[3] China Academy of Chinese Medical Sciences,Institute of Basic Research in Clinical Medicine
[4] Yiling Hospital Affiliated to Hebei Medical University,Department of Endocrinology
来源：
Chinese Journal of Integrative Medicine | 2016年 / 22卷
关键词：
cardiovascular disease; fibrinogen; diabetes; bromelain; randomized control trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：728 / 737
页数：9
相关论文
共 50 条
  • [41] A Combination of Prebiotic Inulin and Oligofructose Improve Some of Cardiovascular Disease Risk Factors in Women with Type 2 Diabetes: A Randomized Controlled Clinical Trial
    Aliasgharzadeh, Akbar
    Khalili, Mohammad
    Mirtaheri, Elham
    Gargari, Bahram Pourghassem
    Tavakoli, Farnaz
    Farhangi, Mahdieh Abbasalizad
    Babaei, Hossein
    Dehghan, Parvin
    ADVANCED PHARMACEUTICAL BULLETIN, 2015, 5 (04) : 507 - 514
  • [42] Metabolic and clinical responses to Bunium Persicum (black caraway) supplementation in overweight and obese patients with type 2 diabetes: a double-blind, randomized placebo-controlled clinical trial
    Jafari-Maskouni, Saber
    Shahraki, Mansour
    Daneshi-Maskooni, Milad
    Dashipour, Alireza
    Shamsi-Goushki, Ali
    Mortazavi, Zinat
    NUTRITION & METABOLISM, 2020, 17 (01)
  • [43] Refined Deep Seawater Improves Serum Lipid Profile in Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
    Kim, Min-Jee
    Lim, Chi-Yeon
    Lee, Kyu-Shik
    Nam, Kyung-Soo
    Kim, Hojun
    JOURNAL OF MEDICINAL FOOD, 2020, 23 (08) : 886 - 894
  • [44] Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial
    Bays, Harold E.
    Hallen, Jonas
    Vige, Runar
    Fraser, David
    Zhou, Rong
    Hustvedt, Svein Olaf
    Orloff, David G.
    Kastelein, John J. P.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) : 181 - 191
  • [45] The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Li, Meijuan
    Liu, Ying
    Qiu, Yuying
    Zhang, Jing
    Zhang, Yonghui
    Zhao, Yongping
    Jia, Qiong
    Li, Jie
    PSYCHIATRY RESEARCH, 2021, 300
  • [46] Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
    Lu, Juming
    Fu, Liujun
    Li, Yan
    Geng, Jianlin
    Qin, Li
    Li, Ping
    Zheng, Hailong
    Sun, Zilin
    Li, Yanbing
    Zhang, Lihui
    Sun, Yadong
    Chen, Daoxiong
    Qin, Guijun
    Lu, Weiping
    Guo, Yushan
    Zhang, Yuwei
    Liu, Haiyan
    Zhang, Tao
    Zou, Jianjun
    DIABETES OBESITY & METABOLISM, 2021, 23 (05) : 1111 - 1120
  • [47] Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial
    Krivoy, Amir
    Onn, Roy
    Vilner, Yael
    Hochman, Eldar
    Weizman, Shira
    Paz, Amir
    Hess, Shmuel
    Sagy, Roi
    Kimhi-Nesher, Shiri
    Kalter, Ehud
    Friedman, Tal
    Friedman, Zvi
    Bormant, Gil
    Trommer, Sharon
    Valevski, Avi
    Weizman, Abraham
    EBIOMEDICINE, 2017, 26 : 138 - 145
  • [48] Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
    Ji, Linong
    Lu, Jinmiao
    Gao, Leili
    Ying, Changjiang
    Sun, Jiao
    Han, Jie
    Zhao, Wenhua
    Gao, Yunming
    Wang, Kun
    Zheng, Xin
    Xie, Daosheng
    Ding, Juping
    Zhao, Jiahong
    Yu, Qiang
    Wang, Tong
    DIABETES OBESITY & METABOLISM, 2023, 25 (12) : 3671 - 3681
  • [49] Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial
    Sohn, Minji
    Park, Young Ho
    Lim, Soo
    DIABETES OBESITY & METABOLISM, 2025, 27 (03) : 1350 - 1358
  • [50] The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomize Double Blind, Placebo-controlled Trial
    Shafabakhsh, Rana
    Asemi, Zatollah
    Reiner, Zeljko
    Soleimani, Alireza
    Aghadavod, Esmat
    Bahmani, Fereshteh
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2020, 14 (04) : 290 - 299
12345